Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30268% above fair value
$116.61+9.13 (+8.49%)
Close on Nov 17, 2026Market cap $8.03BP/E –Yield –
Rhythm Pharmaceuticals revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Rhythm Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $239.92M, up 53.5% year over year. For fiscal 2025 it was $189.76M, up 45.8% from the year before. The highest annual figure on record is $189.76M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $189.76M | +45.8% |
| FY2024 | Dec 31, 2024 | $130.13M | +68.1% |
| FY2023 | Dec 31, 2023 | $77.43M | +227.6% |
| FY2022 | Dec 31, 2022 | $23.64M | +649.5% |
| FY2021 | Dec 31, 2021 | $3.15M | – |
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $71.26M | +46.9% |
| Q1 FY2026 | Mar 31, 2026 | $60.11M | +83.8% |
| Q4 FY2025 | Dec 31, 2025 | $57.25M | +36.9% |
| Q3 FY2025 | Sep 30, 2025 | $51.30M | +54.3% |
| Q2 FY2025 | Jun 30, 2025 | $48.50M | +66.8% |
| Q1 FY2025 | Mar 31, 2025 | $32.70M | +25.9% |
| Q4 FY2024 | Dec 31, 2024 | $41.83M | +72.6% |
| Q3 FY2024 | Sep 30, 2024 | $33.25M | +47.8% |
| Q2 FY2024 | Jun 30, 2024 | $29.08M | +51.3% |
| Q1 FY2024 | Mar 31, 2024 | $25.97M | +126.4% |
| Q4 FY2023 | Dec 31, 2023 | $24.23M | +175.7% |
| Q3 FY2023 | Sep 30, 2023 | $22.50M | +425.3% |
| Q2 FY2023 | Jun 30, 2023 | $19.22M | +112.0% |
| Q1 FY2023 | Mar 31, 2023 | $11.47M | +665.6% |
| Q4 FY2022 | Dec 31, 2022 | $8.79M | +383.8% |
| Q3 FY2022 | Sep 30, 2022 | $4.28M | +316.7% |
| Q2 FY2022 | Jun 30, 2022 | $9.07M | +3208.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.50M | +4180.0% |
| Q4 FY2021 | Dec 31, 2021 | $1.82M | – |
| Q3 FY2021 | Sep 30, 2021 | $1.03M | – |
| Q2 FY2021 | Jun 30, 2021 | $274.00K | – |
| Q1 FY2021 | Mar 31, 2021 | $35.00K | – |
See a number that looks wrong?